BD dives on Q1 profit slide, lowered guidance

Becton, Dickinson & Co.

Shares of Becton, Dickinson & Co. (NYSE:BDX) continued their slide today after closing down yesterday following the release of the medical products giant’s fiscal 1st quarter results.

Investors, reacting to a lower forecast for the rest of the year and to a nearly 17% profit slide, sent shares down to $77.51 last night, a 3.8% decline. Shares were trading at $76.89 as of about 12:50 p.m. today, down 0.8%.

Becton, Dickinson posted profits of $263.0 million, or $1.21 per diluted share, on sales of $1.89 billion during the 3 months ended Dec. 31, 2011. That’s a top-line gain of 2.5% but a bottom-line decline fo 16.8%, compared with Q1 2011.

Excluding a 1-time tax gain of 4 cents per share, adjusted EPS was in line with analysts’ expectations at $1.21 apiece.

“We are pleased with our solid start to fiscal year 2012 given the challenging macroeconomic climate,” president & CEO Vincent Forlenza said in prepared remarks. “Our operating results reflect our increased investments in high-growth areas. We will continue to drive efficiency throughout the Company and we remain committed to delivering value to our customers and shareholders.”

CFO David Elkins told analysts on a conference call that BD now expects full-year sales growth to be flat due to a stronger dollar. The company had predicted sales growth of 1% to 3% for fiscal 2012. Earnings per share are now pegged to run between $5.60 and $5.70 for the full year, down from $5.75 to $5.85.

"While we don’t normally provide guidance for the quarter, I would like to outline our expectations for the 2nd quarter," Elkins said. "In our Medical surgical systems business, we expect growth rates to improve in the 2nd half of the year as we move past pricing comparisons.

"From an EPS perspective, we anticipate earnings per share to be between $1.36 and $1.40, or about flat versus the prior period. Second-quarter EPS growth versus the prior-year period will continue to be unfavorably impacted by tough comparisons in 2011. These tough comparisons include price erosion and increased investments in SG&A, which began in the 2nd half of fiscal year 2011 and will continue through the 2nd quarter of fiscal year 2012," he said. "We expect a step-up in EPS growth during the 2nd half of the year once we move past the difficult comparisons of 2011."

Sales for BD Medical rose by 2.3% during the quarter, driven by a 17.5% gain from its pharmaceuticals business, which added $60.7 million to the top line. Sales for BD’s medical surgical systems segment slid 2.3% to $248.4 million during the quarter; diabetes care sales rose 6.0% to $105.5 million.

Elkins said the company is expecting more from the division during the full year.

"We are raising the lower end of our medical segment guidance and expect revenues to grow between 2% and 3%," he said, noting that BD expects the pricing pressure that eroded that business during the second half of 2011 to ease during the second half of this year. "So we will see improvement in U.S. as that tough comparison goes away. And then overall, we’re seeing very good growth and increased confidence internationally on med/surg business. Those 2 factors combined is why we’re bringing up the bottom end of the range on the medical segment overall."

RSS From Medical Design & Outsourcing

  • Saelig presents new Amplicon Impact-R 1100F series computer
    Saelig Company announces the Amplicon Impact-R 1100F series, a fanless system powered by the Intel ATOM D2550 processor. Configured with a high performance 2.5 in. MLC Solid State Drive (SSD), the Impact-R 1100F series is a silent controller system. With options for multiple serial communication ports, the Impact-R 1100F can offer up seven DB9 connections […]
  • Gerresheimer to acquire Centor
    Gerresheimer AG, a partner to the global pharmacy and healthcare industry, will further extend its pharmaceutical packaging business with the acquisition of Centor. Gerresheimer has reached an agreement with Nemera Development S.A. to acquire 100% of the share capital of Centor US Holding. “Centor is the highly profitable market leader for plastic vials and closures in […]
  • Methods Machine Tools presents the new Nakamura-Tome NTRX-300
    Methods Machine Tools, a developer of precision machine tools and automation, has introduced the new Nakamura-Tome NTRX-300, a multitasking turning center featuring complete parts machining in one operation, with a built-in load and unload automation system and advanced operator recognition management software. The NTRX-300 features true opposing twin spindles: an 8 in. A2-6 25 HP or […]
  • MSC Apex Diamond Python and Smart Midsurface speeds modeling to validation
    MSC Software announced a new release of MSC Apex, the company’s award-winning next generation Computer Aided Engineering (CAE) platform. The MSC Apex Diamond Python release introduces: · The fourth release of MSC Apex Modeler is a CAE Specific direct modeling and meshing solution that streamlines CAD clean-up, simplification and meshing workflow. New in this release is […]
  • Quality Metrics: FDA’s plan for a key set of measurements to help ensure manufacturers are producing quality medications
    Editor’s Note: This article is written by Ashley Boam and Mary Malarkey from the “FDA Voice” blog. Boam is an FDA’s acting Director of the Office of Policy for Pharmaceutical Quality, the Office of Pharmaceutical Quality and the Center for Drug Evaluation and Research. Malarkey is an FDA’s Director if the Office of Compliance and Biologics Quality […]
  • MasterControl’s CEO talks EQMS software and new partnerships
    MasterControl offers a quality and compliance software that helps device companies speed time to market and improve their bottom lines. Under Jon’s leadership, the company has blossomed into a market leader and has a unique corporate culture that fosters growth, excellence and quality. In this podcast, MasterControl’s CEO, Jon Beckstrand, will discuss electronic quality management […]
  • BIT Group launches white label IVD solutions
    BIT Group has launched a product line of customizable IVD white label instruments. During recent years, BIT has invested capital and resources developing customizable, ready-to-use IVD systems to address a growing demand. “The IVD market is challenging for our clients,” said Marius Balger, CEO at BIT. “OEM’s must adhere to a growing number of evolving IVD […]
  • Toshiba expands line-up of ARM Cortex-M-based microcontrollers
    Toshiba announced that it has enhanced its current “TX Family” of ARM core-based microcontrollers and started to develop three series of microcontrollers, “TXZ0 series,” “TXZ3 series” and “TXZ4 series,” as part of the “TXZTM Family.” The TXZTM Family is a new collection of flash microcontrollers that support low-power consumption and high-speed operation for IoT and M2M […]
  • Parker Hannifin consolidates, layoffs ahead
    Parker Hannifin plans to consolidate a number of internal divisions, close 2 facilities and expand its Mexican operations, according to an internally distributed letter from Andy Ross, Parker’s engineered materials group president. The company has confirmed the letter was authentic, but has not disclosed how many employees will be affected by the new plans or […]
  • 3-phase current transducer from PEM delivers all-in-one convenience
    The new RCTrms 3-ph current transducer from Power Electronic Measurements (PEM) delivers a convenient, safe and accurate solution for measuring current in three phases. It features a thin, clip-around, flexible sensor coil and provides accurate true rms measurement with 4-20 mA or 0-5 V output, enabling simple installation with PLC’s, SCADA systems or automation equipment. […]
  • Safety alert: Recall on two IV solutions from Baxter
    Baxter International announced it is voluntarily recalling two lots of intravenous (IV) solutions to the hospital and user level due to the potential presence of particulate matter. The particulate matter in each case was determined to be an insect and was identified as a result of a customer complaint. The matter was identified prior to […]

Leave a Reply